SCHEMBL26548847

SCHEMBL26548847

FC(F)(F)c1ccc(-c2ccc(-c3ccc4ccc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)cc4c3)cn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 2/20 0.45
IDO1 P14902 1/20 0.45
KDM1A O60341 3/20 0.45
MAOB P27338 1/20 0.45
KIF11 P52732 1/20 0.41
TOP1 P11387 2/20 0.39
TDP1 Q9NUW8 1/20 0.38
ALOX5AP P20292 3/20 0.37
FEN1 P39748 3/20 0.37
DGAT1 O75907 1/20 0.37
PPARA Q07869 1/20 0.37
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548363 0.95 IDO1 (0.46) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548858 0.94 KDM1A (0.47) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548862 0.94 KDM1A (0.49) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548721 0.93 S1PR1 (0.44) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548844 0.92 KDM1A (0.48) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548840 0.92 TDP1 (0.44) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26549319 0.89 IDO1 (0.42) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548692 0.89 KDM1A (0.42) KDM1AMAOBTDP1ALOX5APFEN1
SCHEMBL26548208 0.89 S1PR1 (0.45) TDO2IDO1KDM1AMAOBKIF11
SCHEMBL26548354 0.88 KDM1A (0.49) TDO2IDO1KDM1AMAOBKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 TDO2 1074/4885IDO1 2053/4885KDM1A 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.